Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials Article

publication date

  • December 1, 2022

webpage

published in

start page

  • 44

end page

  • 50

volume

  • 116